DAPA: Dapagliflozin in Acute Heart Failure
This double-blind drug study enrolls patients currently hospitalized with acute heart failure who will be randomized to Dapagliflozin or placebo treatment arms.
Previous
Previous
VALOR:QI
Next
Next